Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vernonia guineensis aqueous extract (AEVG) is a botanical research compound derived from the leaves, roots, or tubers of the *Vernonia guineensis* Benth. plant, which is native to West and Central Africa and used in traditional Cameroonian medicine. The extract contains a variety of bioactive phytochemicals, including sesquiterpene lactones, flavonoids, and tannins. Preclinical research has explored its potential therapeutic applications in non-alcoholic fatty liver disease (NAFLD) due to its lipotropic properties, as well as its anti-inflammatory, antiplasmodial, anthelmintic, and anti-cancer activities (specifically against prostate cancer). It is currently an academic research tool and has not been developed into a commercial pharmaceutical product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vernonia guineensis aqueous extract.